HMGB‐1 Mediates The Exacerbation of Anaphylactic Shock Under Hyperlipidemic Conditions
Journal of Cellular Physiology · 2026
DOI: 10.1002/jcp.70154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2026. Verfasst von Zikang Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Anaphylaxis, HMGB1 Protein, Hyperlipidemias. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Heilong jiang Provincial Natural Science Foundation, Harbin Medical University Postgraduate Research and Practical Innovation Project.
Abstract (Originalsprache)
Coronary heart disease (CHD) may worsen anaphylactic shock, but the exact mechanism is unknown. This study aimed to investigate the mechanisms by which coronary heart disease exacerbates anaphylaxis.C57BL/6 (WT) mice and LDLR −/− mice were fed a high‐fat diet for 20 weeks to develop atherosclerosis. Anaphylaxis was then induced using ovalbumin (OVA). Compared to WT mice, LDLR −/− mice showed lower body temperature, worse pulmonary edema and higher mortality. Pulmonary endothelial cell CD31 (PECAM‐1) expression decreased, but serum HMGB‐1 levels increased. In vitro experiments found that ox‐LDL exposure led to more HMGB‐1 release from HUVECs. Moreover, ox‐LDL induced mast cells release of histamine, upregulating the expression of more H1 receptors (H1R) in HUVECs, thereby further promoting HMGB‐1 release. Pretreatment with an H1R inhibitor (chlorpheniramine) or an HMGB‐1 neutralizing antibody improved survival and attenuated hypothermia in mice. In summary, ox‐LDL exacerbates endothelial cell damage, resulting in increased HMGB‐1 release and vascular permeability, which may worsen anaphylaxis to anaphylactic shock. The mechanisms are not fully understood, but HMGB‐1 could be a potential target for future alleviation of anaphylactic shock.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Forensic Medicine, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Pathophysiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Pathology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China.
ORCID-Profile: He Chen
Förderung
- Heilong jiang Provincial Natural Science Foundation
- Harbin Medical University Postgraduate Research and Practical Innovation Project
Zitieren
APA
Liu, Z., Ding, T., Wan, J., Fan, Z., Yue, Z., Pang, K., Jin, Z., Yang, W., Zhang, W., & Chen, H. (2026). HMGB‐1 Mediates The Exacerbation of Anaphylactic Shock Under Hyperlipidemic Conditions. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70154
Vancouver
Liu Z, Ding T, Wan J, Fan Z, Yue Z, Pang K, et al. HMGB‐1 Mediates The Exacerbation of Anaphylactic Shock Under Hyperlipidemic Conditions. Journal of Cellular Physiology. 2026. doi:10.1002/jcp.70154
BibTeX
@article{Liu2026,
author = {Liu, Zikang and Ding, Tingting and Wan, Jing and Fan, Zhihao and Yue, Ziqi and Pang, Kemiao and Jin, Zhanfeng and Yang, Weiwei and Zhang, Weihua and Chen, He},
title = {HMGB‐1 Mediates The Exacerbation of Anaphylactic Shock Under Hyperlipidemic Conditions},
journal = {Journal of Cellular Physiology},
year = {2026},
doi = {10.1002/jcp.70154}
}
EUVIMED